XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Note 13 - Loss Per Share
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 13 LOSS PER SHARE

 

The following table presents the shares used in the basic and diluted loss per common share computations:

 

    Three Months Ended September 30,     Nine Months Ended September 30,   
   

2025

   

2024

   

2025

   

2024

 

Numerator:

                               

Net (loss) from continuing operations

  $ (77,646,737 )   $ (2,129,880 )   $ (81,911,048 )   $ (8,150,654 )

Net (loss) from discontinued operations

    (5,106 )     (964,810 )     (254,130 )     (2,344,140 )

Net (loss) attributable to common stockholders

  $ (77,651,843 )   $ (3,094,690 )   $ (82,165,178 )   $ (10,494,794 )
                                 

Denominator:

                               

Weighted average common shares outstanding - basic

    723,998       426,423       603,605       336,423  

Effect of diluted stock options, warrants, and preferred stock (1)

    -       -       -       -  

Weighted average common shares outstanding - diluted

    723,998       426,423       603,605       336,423  
                                 

Net (loss) from continuing operations attributable to common stockholders per common share – basic and diluted

  $ (107.24 )   $ (4.99 )   $ (135.70 )   $ (24.23 )

Net (loss) from discontinued operations attributable to common stockholders per common share – basic and diluted

    (0.01 )     (2.27 )     (0.42 )     (6.97 )

(Loss) per common share - basic and diluted

  $ (107.25 )   $ (7.26 )   $ (136.12 )   $ (31.20 )

 

 

(1)

The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive:

 

   

Three and Nine Months Ended

September 30,

 
   

2025

   

2024

 

Options

    2,936       3,013  

Warrants

    58,267       183,362  
Restricted stock units     60,101       -  

Preferred stock: Series B

    2       2